tiprankstipranks
Enliven Therapeutics, Inc. (ELVN)
NASDAQ:ELVN
US Market
Want to see ELVN full AI Analyst Report?

Enliven Therapeutics (ELVN) Blogger Opinions & Sentiment

345 Followers

Blogger Sentiment

Bearish: 70.00%
Sector Average
Bearish
ELVN Blogger sentiment is based on 3 Blogger Opinions. The Blogger sentiment is more Bearish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
66% GuruFocus
34% SeekingAlpha
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Insider Sell Alert: Lori Kunkel Sells 10,000 Shares of Enliven Therapeutics Inc (ELVN)
GuruFocus
Enliven Therapeutics: Continuing The Pop Off; What Could Go Wrong?
SeekingAlpha
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

Ero Copper: A Copper Growth Story Trading at a Discount
GuruFocus
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of ELVN?
Seeking Alpha’s Galzus Research has a Bearish Sentiment.
    What do Motley Fool contributors think of ELVN?
    Currently there's no blogger sentiment for ELVN.
    What Is ELVN’s Blogger Sentiment?
    ELVN’s Blogger Sentiment is Bearish.
      What was the most recent blogger prediction for ELVN?
      The most recent blogger prediction for ELVN was made by GuruFocus News, who was Bearish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          CAPRCapricor Therapeutics
          PMCUFPro Medicus Limited
          TGTXTG Therapeutics
          NURPFNeuren Pharmaceuticals Limited
          GALTGalectin Therapeutics